The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Molecular genetic testing patterns for patients with newly diagnosed acute myeloid leukemia (AML) enrolled in the CONNECT MDS/AML disease registry.
 
Daniel Aaron Pollyea
Consulting or Advisory Role - Alexion Pharmaceuticals; Ariad; Celgene; Karyopharm Therapeutics; Pfizer
Research Funding - Celgene
 
Tracy George
No Relationships to Disclose
 
Kathryn M Foucar
Consulting or Advisory Role - Celgene
 
Harry Paul Erba
Consulting or Advisory Role - Amgen; Celator/Jazz; Celgene; Daiichi Sankyo; ImmunoGen; Incyte; Millennium; Novartis; Ono Pharmaceutical; Pfizer; Seagen; Sunesis Pharmaceuticals
Speakers' Bureau - Celgene; Incyte; Novartis
Research Funding - Agios (Inst); Amgen (Inst); Astellas Pharma (Inst); Celator (Inst); Daiichi Sankyo (Inst); ImmunoGen (Inst); Janssen (Inst); Juno Therapeutics (Inst); Millennium (Inst); Seagen (Inst)
Other Relationship - Celgene; GlycoMimetics
 
Michael A. Thompson
Stock and Other Ownership Interests - Doximity
Consulting or Advisory Role - AIM Specialty Health; Bristol-Myers Squibb; Celgene; Takeda; VIA Oncology
Other Relationship - Doximity
 
Mehrdad Abedi
Consulting or Advisory Role - Celgene
Speakers' Bureau - Bristol-Myers Squibb; Celgene; Seagen; Takeda
Research Funding - Amgen; Celgene; Takeda
 
Gail J. Roboz
Consulting or Advisory Role - Agios; Amgen; Amphivena; Astex Pharmaceuticals; AstraZeneca; Boehringer Ingelheim; Celator; Celgene; Cellectis; CTI; Genoptix; GlaxoSmithKline; Janssen; Juno Therapeutics; MedImmune; MEI Pharma; Novartis; Onconova Therapeutics; Pfizer; Roche; Shire; Sunesis Pharmaceuticals
Research Funding - Abbvie (Inst); Agios (Inst); Astex Pharmaceuticals (Inst); Celgene (Inst); Cellectis (Inst); CTI (Inst); Karyopharm Therapeutics (Inst); MedImmune (Inst); MEI Pharma (Inst); Moffitt (Inst); Novartis (Inst); Onconova Therapeutics (Inst); Pfizer (Inst); Sunesis Pharmaceuticals (Inst); Tensha Therapeutics (Inst)
Travel, Accommodations, Expenses - Amphivena; Astellas Pharma; Astex Pharmaceuticals; AstraZeneca; Celator; Incyte; Janssen; Juno Therapeutics; MEI Pharma; Roche; Shire
 
Danny Landau
Speakers' Bureau - Alexion Pharmaceuticals; Bristol-Myers Squibb; Celgene; Genentech; Novartis; Sanofi
 
John M. Pagel
Consulting or Advisory Role - Gilead Sciences; Pharmacyclics
 
Karen Seiter
Employment - Hudson Valley Cancer Center
Honoraria - Novartis
Consulting or Advisory Role - Alexion Pharmaceuticals; Celgene; Incyte; Novartis
Speakers' Bureau - Alexion Pharmaceuticals; Celgene; Incyte; Novartis
Research Funding - Astellas Pharma (Inst); celgene (Inst); Daiichi Sankyo (Inst); FORMA Therapeutics (Inst); incyte (Inst); Janssen (Inst); Jazz Pharmaceuticals (Inst); Novartis (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Agios; Celgene; Novartis
 
Christopher R. Cogle
Consulting or Advisory Role - Celgene
Expert Testimony - IMS Health
 
Melissa Nifenecker
Employment - Celgene
Stock and Other Ownership Interests - Celgene
 
Arlene S. Swern
Employment - Celgene
Stock and Other Ownership Interests - Celgene
 
Pavel Kiselev
Employment - Celgene
Stock and Other Ownership Interests - Celgene
Consulting or Advisory Role - Celgene
Travel, Accommodations, Expenses - Celgene
 
Mary M. Sugrue
Employment - Celgene
Stock and Other Ownership Interests - Celgene